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Abstract
Considerable quantitative variations in the competitive inhibition of NADH oxidase activity of bovine heart submito-
 . q  .chondrial particles SMP by different samples of NAD were observed. ADP-ribose ADPR was identified as the
inhibitory contaminating substance responsible for variations in the inhibition observed. ADPR competitively inhibits
 .NADH oxidation with K values 258C, pH 8.0 of 26 mM, 30 mM, and 180 mM for SMP, purified Complex I andi
 .three-subunit NADH dehydrogenase FP , respectively. ADPR decreases NADH-induced flavin reduction and prolongs the
cyclic bleaching of FP during aerobic oxidation of NADH. K for inhibition of the rotenone-sensitive NADH oxidase ini
q
qSMP by ADPR does not depend on Dm . The initial rate of the energy-dependent NAD reduction by succinate isH
insensitive to ADPR. The inhibitor increases the steady-state level of NADq reduction reached during aerobic succinate-
supported reverse electron transfer catalyzed by tightly coupled SMP. The results obtained are consistent with the proposal
on different nucleotide-binding sites operating in the direct and reverse reactions catalyzed by the mitochondrial
NADH-ubiquinone reductase.
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.drion
1. Introduction
Despite the significant progress in the structural
studies on the proton-pumping NADH-quinone re-
 . w xductases EC 1.6.99.3, Complex I 1–3 the knowl-
edge on the molecular mechanisms of the substrate
dehydrogenation, intramolecular electron transfer and
Abbreviations: SMP, submitochondrial particles; FP, three
subunit iron-sulfur-flavoprotein derived from Complex I; ADPR,
ADP-ribose; FMN, flavin mononucleotide; rhein, 9,10-dihydro-
4,5-dihydroxy-9,10-dioxo-2-anthracene carboxylic acid.
)  .  .Corresponding author. Fax: 7 095 939-39-55; E-mail:
adv@biochem.bio.msu.su
vectorial proton transfer is still at the primitive stage.
The enzyme is composed of more than 40 distinct
subunits, which are spatially arranged in such a way
 .that the hydrophilic substrate or product interacts
with the peripheral FMN-iron-sulfur containing
 . w xthree-subunit part FP 4–6 . The derived electrons
reach intramembraneously located quinone reduction
 . w xsite s 7–10 travelling through a number of iron-
w xsulfur clusters 11–13 presumably located in the
 . w xconnecting part IP 7,14 .
Membrane-bound Complex I and simpler NADH
 .dehydrogenase preparations FP derived from the
original enzyme catalyze FMN-mediated stereospe-
w 3 xcific 4B- H oxidation of NADH and rapid tritium-
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w xH O exchange 15–17 . Significant variations in the2
apparent NADH affinity to the substrate binding site
determined by the kinetic methods are scattered in
w xthe earlier literature 4,18–22 . The isolated respira-
tory chain-linked NADH dehydrogenase besides
NADH oxidizes acetyl pyridine-NADH, pyridine
aldehyde-N A D H , thionicotinam ide-N A D H ,
w xdeamino-NADH and NADPH 23 . Only deamino-
NADH is oxidized at the rate comparable with that of
NADH, and this was used to discriminate between
energy-transforming and non-energy transforming
w xbacterial NADH-quinone oxidoreductases 24,25 .
 .Bovine heart submitochondrial particles SMP and
the soluble partially purified NADH dehydrogenase
are capable of NADPH oxidation with the pH-profile
w xmarkedly different from that for NADH 26,27 . The
 .catalytic sector of Complex I FP catalyzes NADPH
q  q.“ NAD acetyl-NAD and NADH “ acetyl-
NADq transhydrogenase reactions with the pH-pro-
files very similar to those for NADPH and NADH
w xoxidation, respectively 28,29 . Two nucleotide-bind-
ing site model has been proposed to explain trans-
w xhydrogenase activity of FP 29 . The observations on
Fe-S clusters reduction by NADH or NADPH and
studies on stoichiometry of the piericidin-induced
inhibition of NADH and NADPH oxidation has led
Albracht and associates to propose a heterodimeric
structure for bovine heart Complex I which is com-
posed of NADH-specific and NADPH-specific pro-
w xtomers 30–32 . The modified heterodimeric model
with three separate pathways for oxidation of reduced
pyridine nucleotides has been proposed to explain the
inhibition pattern for thirteen different compounds
w xmainly substituted carbocyanine dyes 33 .
In addition to NADH oxidase activity tightly cou-
pled bovine heart SMP catalyze the energy-dependent
w 3 x qrotenone-sensitive stereospecific 4B- H NAD and
q w xNADP reduction 16,26,34 which is believed to be
a simple reversal of the proton-pumping NADH-
ubiquinone reductase reaction.
The largest subunit of FP which contains FMN and
N-3 iron-sulfur cluster has been identified as a
NADH-binding subunit of mammalian and bacterial
w xComplex I 35–38 . The conserved structural motifs
of the primary structures of the bovine 51 kDa sub-
w x ( ) w x ( )unit 39 , and its P. denitrificans 3 and N. crassa
w x40 counterparts has been recognized as the most
likely candidate for the NADH-binding site. An addi-
tional segment of sequence that fits the nucleotide
binding site has been identified in 39 kDa subunit of
w xbovine Complex I 41 and in the homologous 40
( ) w xkDa subunit of N. crassa complex 42 .
Previous studies have revealed rhein as the only
reversible inhibitor acting on the substrate side of the
w xflavin 43,44 . Purely competitive inhibition with re-
 .spect to substrate s has been documented for
NADH-ferricyanide reductase and NADH“acetyl-
q w xNAD transhydrogenase activities 44 . Rhein was
shown not to affect NADH-acceptor reductase activ-
ity catalyzed by FP low molecular mass NADH
.dehydrogenase ; more complex inhibition than of
purely competitive kinetics was found for NADH-
ferricyanide reductase and ATP-driven reduction of
NADq by succinate which are catalyzed by the mem-
w xbrane bound Complex I 44 . It seems rather surpris-
ing that neither adenosine nor nicotinamide mononu-
 .cleotide oxidized or reduced are the inhibitors of
NADH oxidation while ATP, ADP, and AMP inhibit
Table 1
 .Kinetic parameters of ADPR-sensitive NADH oxidation by the respiratory chain-linked NADH dehydrogenase 258C, pH 8.0
NADH NADq ADPR .  .  .Enzyme preparation Electron acceptor K mM K mM K mMm i i
a .  .SMP coupled O NADH oxidase 1.4 1.1 242
b .  .SMP uncoupled O NADH oxidase 2.2 1.2 252
 .SMP Ferricyanide 0.5 mM 14 1.2 26
 .Complex I Ferricyanide 0.5 mM 31 1.2 30
 .FP Ferricyanide 0.5 mM 47 2.0 1.250
y  .FP q70 mM guanidinerCl Ferricyanide 0.5 mM 28 y 180
 .FP Hexammineruthenium III 0.5 mM 180 y 800
The precision of the values given was about 10%.
a  .Particles were preincubated in the presence of oligomycin 0.6 nmol per mg protein as described in Fig. 6.
b a.  .The same as before , gramicidin 0.1 mgrml was added to the assay mixture.
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Fig. 1. Inhibition of the NADH oxidase by NADq. The initial
 .rates ˝ , mmol per min per mg of protein of NADH oxidation0
 .by SMP in the presence of gramicidin uncoupled respiration
were measured after ‘activation’ of NADH-Q reductase by the
addition and complete oxidation of 5 mM NADH. 1, no NADq
 qwas added control, 5 mM NAD formed from NADH added for
. qactivating pulse was present . The additions of 1 mM NAD
were: 2, Sigma, grade V; 3, Sigma, grade III C; 4, Reanal; 5, as
2, the stock solution of 100 mM NADq in water was kept for 48
h at room temperature.
 y2 . w xat very high concentrations about 10 M 45 .
Moreover, NADq, which appears to be the closest
analogue of NADH, is a weak competitive inhibitor
 . w xof NADH oxidation K is about 1 mM 4,22,46i
whereas it is the substrate for the energy-dependent
reverse reaction with the apparent affinity in micro-
w xmolar range 46 . The uncompetitive inhibition of FP
q  .by low concentration of NAD K s25 mM hasi
been reported, which was dependent on the nature of
w xan artificial electron acceptor 47 .
No clear-cut model for the arrangement of nu-
 .cleotide-binding site s in Complex I can be con-
structed yet. The use of the competitive substrate-bi-
nding site inhibitors seems to be a powerful tool for
further understanding of Complex I reaction mecha-
nism. In this report we will characterize ADP-ribose
 .ADPR as a competitive inhibitor of NADH oxida-
tion. Inability of ADPR to inhibit the reverse reaction
is considered as an indication for the presence of two
qdifferent nucleotide-binding sites operating in Dm -H
qgenerating NADH oxidation and in Dm -consumingH
NADq reduction.
2. Materials and methods
w x w xSubmitochondrial particles 48 , Complex I 49
and soluble three subunits NADH dehydrogenase
 . w xFP 5 were prepared according to the published
procedures and stored in liquid nitrogen. Protein con-
w xtent was determined with the biuret reagent 50 .
Fig. 2. Effect of NADq hydrolytic decomposition on the efficiency of NADH oxidase inhibition. A: 100 mM freshly prepared aqueous
q  .solution of NAD was kept at 1008C for the time min indicated by the figures on the lines and NADH oxidase was assayed as
q  .  . q qdescribed in Fig. 1 in the presence of 1 mM NAD assumed concentration . v no NAD was added. B: inhibitory effect of NAD
 . q  . qcurve 1, left ordinate and actual NAD content curve 2, right ordinate as a function of NAD hydrolysis time-course. 8 mM NADH
was used as the substrate.
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Enzymatic activities were measured at 258C in the
standard reaction mixture containing: 0.25 M sucrose,
y  .0.2 mM EDTA, and 20 mM TrisrCl SMP or 20
 .mM potassium phosphate Complex I and FP , pH
8.0. The rates of NADH oxidation or NADq reduc-
 mM .tion were followed at 340 nm E s6.2 or at 420340
 mM .nm ferricyanide reductase, E s1.0 . NADH-420
ubiquinone reductase in SMP was pulsed aerobically
with 5 mM NADH to activate the enzyme before the
NADH oxidase and reverse electron transfer activi-
w xties were measured 48 . All the activities are ex-
pressed as the initial rates of NADH oxidation or
q  .NAD reduction ˝ , mmol per min per mg protein .0
Other details of the assays are indicated in the leg-
ends to figures and Table 1.
Chromatographic purification of NADq hydrolysis
products was performed on DEAE-cellulose column
w x q51 . Salt-free NAD hydrolysis products were col-
w xlected using Sephadex G-10 column 52 . The homo-
geneous products of NADq hydrolysis were identi-
fied by thin-layer chromatography on Silica gel plates
 .with a butanolracetic acidrH O mixture 5:2:3, vrv2
as the solvent. The enzymatic hydrolysis of NADq
was carried out as follows: 1 unit of NADq glycohy-
 .drolase NADase EC 3.2.2.5, Sigma N-5263 was
q  .added to 1 ml of 0.1 M solution of NAD pH 7.5
and the mixture was incubated at 378C for 1.5 h. The
reaction was followed by measuring the cyanide-ad-
 mM .duct formation at 327 nm E s5.9 in the mixture327
containing 50 mM TrisrCly and 1 M KCN, pH 9.0
w x q53 . The concentration of NAD was measured en-
zymatically with yeast alcohol dehydrogenase EC
. w x1.1.1.1 54 .
The sources of the chemicals were as follows:
NADH, NADq, rotenone, oligomycin, gramicidin,
 .NADase, ADP-ribose were from Sigma USA ;
 .EDTA was from Merck Germany ; DEAE-cellulose
 .and Silica gel plates were from Whatman USA ;
 .Sephadex G-10 was from Pharmacia Sweden . Some
q  .samples of NAD were from Reanal Hungary .
Other chemicals were of the highest quality commer-
cially available.
3. Results
The original aim of these studies was to quantitate
relative affinities of pyridine nucleotides to the sub-
 .strate-binding site s of Complex I as revealed in
different assay systems. We were particularly puzzled
by the significant quantitative difference between the
apparent K NADq for competitive inhibition of NADHi
 . NADqoxidation millimolar range and the apparent Km
 .for the reverse electron transfer micromolar range
w x46 . This prompted us to obtain closer insight into
the kinetic pattern of the inhibition by NADq. Fig. 1
demonstrates that the inhibition of NADH oxidase is
indeed purely competitive. However, we have noticed
that the apparent K values were variable dependingi
on the particular samples of NADq. Although possi-
ble effects of NADq impurities on the kinetics of
several NADHrNADq-dependent dehydrogenases
w xhave been emphasized and extensively discussed 55 ,
Fig. 3. Elution profile for the chromatography of NADq samples
on DEAE-cellulose. A: 1 ml freshly prepared 100 mM NADq
solution was applied on the column 30=3,5 cm and eluted with
w x  .  .NaCl 51 . B: as A after 60 min hydrolysis at 1008C. C: as A
after treatment with NADq-glycohydrolase for 90 min at 378C.
The compounds indicated were identified by thin-layer chro-
matography with the appropriate standards. Shadowed areas indi-
cate the fractions which showed significant inhibitory effect on
NADH oxidase of SMP.
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to our knowledge, no special attention toward this
problem had been paid to the respiratory chain-linked
NADH dehydrogenases. When aqueous NADq solu-
tion adjusted to pH 7.0 was stored for 2 days at 208C,
the apparent K for such samples gradually de-i
creased. The inhibitory potency increased substan-
tially in parallel with NADq content decrease when
the sample of NADq was heated at 1008C for 1 h
 .  .Fig. 2 . To identify the inhibitory substance s , the
heated samples of NADq were subjected to ion-ex-
change chromatography as depicted in Fig. 3. Very
similar chromatographic patterns were found for
‘heated’ NADq and NADq subjected to treatment
q  .with NAD glycohydrolase EC 3.2.2.5 . The only
fraction in hydrolyzed NADq preparations which
showed significant inhibitory effect was that corre-
sponding to ADPR. Thus the inhibition pattern for
ADPR was studied in greater detail. Fig. 4 shows that
the inhibition of the NADH oxidase activity of SMP
by ADPR is purely competitive with respect to sub-
strate. The K value derived from Dixon plot was 26i
mM.
It was of interest to examine whether simpler
enzyme preparations oxidizing NADH are also inhib-
ited by ADPR. Qualitatively the same kinetic patterns
 .as shown in Fig. 4 purely competitive inhibition for
SMP, purified Complex I, and FP with hexam-
.mineruthenium III as electron acceptor were ob-
tained. A slight deviation from purely competitive
inhibition by both NADq and ADPR for FP in the
presence of ferricyanide as an electron acceptor
 .mixes type inhibition was noted. The quantitative
kinetic parameters for NADH oxidation and inhibi-
tion by ADPR are summarized in Table 1. For com-
parison, the data on the competitive inhibition by
chromatographically pure NADq are also presented.
It is worth noting that very close K values werei
found for SMP and Complex I whereas significantly
higher K NADH and K ADPR were determined for FP.m i
This is in agreement with the earlier findings on a
drastic decrease of the apparent affinity of NADH to
the substrate binding site after solubilization of FP
w x29,45,56 . In agreement with the results of Hatefi et
w x NADH ADPRal. 29,45 , both K and K decreased in them i
presence of guanidine.
The effect of ADPR on the NADPH oxidase activ-
ity of SMP at pH 6.5 was tested. A noncompetitive
 ADPR .inhibition K f30 mM was observed. Furtheri
detailed studies are needed for the meaningful inter-
pretation of this phenomenon because of markedly
different pH-profiles and relative turnovers for NADH
and NADPH oxidation and also because of possible
 .involvement of transhydrogenase EC 1.6.1.1 in the
overall NADPH oxidation by SMP.
Further evidence for competition of NADH and
ADPR for the substrate binding site which is equiva-
lent to the inhibition of electron transfer between
NADH and flavin was obtained by the direct mea-
Fig. 4. Competitive inhibition of NADH oxidase activity of SMP by the chromatographycally pure ADPR. A: double-reciprocal plots for
 .NADH oxidation in the presence of different ADPR concentration mM, indicated by the figures on the lines . B: Dixon plot;
 .concentrations of NADH mM are indicated by the figures on the lines.
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surements of FMN redox cycle in FP after the addi-
tion of a limited amount of NADH. It has been
documented that FP is capable of NADH oxidation
coupled with oxygen“superoxide one-electron re-
duction at much lower rate than those observed with
w xother artificial electron acceptors 47,57 . Thus the
redox dependent cyclic bleaching of flavin can be
followed at the relatively high protein concentration
suitable for the direct spectrophotometric registration.
 .When limited amount of NADH 20 mM was added
to the aerobic transparent solution of 0.56 mM FP in
.terms of FMN content an immediate decrease of
absorption at 445 nm was observed followed by
complete reoxidation after a certain time interval
 .Fig. 5 . The cycle could be repeated by further
 .addition of NADH not shown . The presence of
Fig. 5. Three-subunit FP chromophore bleaching by NADH. A:
 .absorption spectra of the enzyme 0.064 mgrml as prepared
 .  .curve 1 and in the presence of 50 mM NADH curve 2 . B:
time course of the NADH-induced bleaching under aerobic con-
ditions. 20 mM NADH was added to 0.48 mM FP solution in 50
 .mM potassium phosphate pH 8.0 , 1 mM EDTA and 70 mM
guanidine; the absorbance change at 445–500 nm was followed
 .in the control sample curve 1 and in the presence of 0.7 mM
 .ADPR curve 2 . The addition of ADPR to the enzyme did not
induce any spectral changes.
Fig. 6. The effect of ADPR on the time-course of the succinate-
supported NADq reduction catalyzed by tightly coupled SMP.
 .SMP 10 mgrml were preincubated for 1.5 h at 258C with
 .oligomycin 0.6 nmol per mg of protein in the mixture contain-
ing: 0.25 M sucrose, 20 mM Tris-Cly, 0.2 mM EDTA, 2 mM
 .malonate potassium salts , pH 8.0. 100 mg of SMP were added
to 2 ml of standard mixture and Complex I was pulsed with 5
mM NADH before the initial rates were measured after simulta-
neous addition of NADq and 10 mM succinate. All the activities
 . were completely blocked by rotenone 2 mM or gramicidin 0.1
. q mgrml . The final NAD concentration was 25 mM 5 mM left
after pulse activation and 20 mM added simultaneousely with 10
.mM succinate where indicated . 350 mM ADPR was present in
 .the assay mixture where indicated left curve .
ADPR decreased the steady-state level of flavin re-
duction and increased the time needed to complete
the redox cycle as expected for the inhibition be-
tween NADH and flavin.
We have also examined the effect of ADPR on
qDm -dependent reverse reaction catalyzed by theH
membrane-bound Complex I. The apparent K NADqm
for this reaction was 15 mM, the value which closely
w xcorresponds to those previously reported 46,58 . Un-
expectedly, the initial rates of the succinate-supported
NADq reduction were negligably affected by ADPR
at any NADq concentration. In fact a slight increase
 .of the initial rates ;20% was observed in the
presence of ADPR. In the separate experiments it was
 .shown that ADPR up to 1 mM concentration did
not affect succinate oxidation rate. An interesting
‘activating’ effect of ADPR was observed when the
steady-state level of NADq reduction was followed
during the aerobic rotenone- and uncoupler-sensitive
 .reverse electron transfer Fig. 6 . The presence of
ADPR significantly increased the extent of NADq
reduction: the ratios NADHrNADq, reached during
oxidation of succinate by tightly coupled SMP re-
.spiratory control ratio of 5.0 in the presence of 25
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mM NADq added were 0.07 and 0.37 with and
without ADPR respectively. The addition of ADPR
after the steady-state level of NADq reduction has
been reached brought about further reduction up to
the level seen in the presence of the inhibitor of
NADH oxidation.
4. Discussion
The present experiments show that ADPR is a
potentially useful compound for studies of the en-
 .zyme substrate-binding site s . The structural analogy
of ADPR with both NADH and NADq is evident and
the kinetic data strongly suggest that the inhibitor
binds with the same catalytic site as does NADH. We
w xhave emphasized earlier 46 that being the substrate
for the reverse electron transfer K is about 20m
. qmM NAD is known to be a very weak competitive
w xinhibitor of NADH oxidation 4,22 . The low affinity
of NADq to the substrate binding site of NADH
oxidase is somehow puzzling because NADq seems
to be the closest analogue of NADH. It may be
speculated that the positive charge in oxidized
nicotinamide moiety plays crucial role in the overall
NADH oxidation catalysis providing the repulsive
force for the product release from the enzyme active
site thus contributing to the reaction energetic profile.
Perhaps the most interesting finding reported here is
that ADPR a competitive inhibitor of NADH oxida-
tion does not inhibit and actually stimulates the
 .qDm -dependent reverse reaction Fig. 6 . SeveralH
possible mechanisms for such a kinetic behaviour
merit brief discussion. It is expected that some prop-
erties of any enzyme functioning as an energy trans-
qducing device must be changed when Dm -on theH
coupling membrane is built up. It is thus conceivable
 .that the affinity for ADPR andror for NADH is
qDm -dependent. Such a proposal, however, seemsH
unlikely because neither apparent K NADH nor K ADPRm i
are significantly different for ‘coupled’ and ‘uncou-
 .pled’ NADH oxidase Table 1 . Another possible
explanation for the absence of ADPR inhibitory ef-
fect on the energy-dependent NADq reduction is that
the precise kinetic mechanisms of the direct and
w xreverse reactions may not be identical 58 . If an
ordered reaction mechanism is operating during
NADH oxidation where the only substrate-free inter-
mediate bears oxidized flavin NADH and ADPR
would compete for the same binding site, providing
that only the FMN -form of the enzyme has highox
affinity for NADH or ADPR. The ordered mecha-
qnism for Dm -dependent reverse reaction can beH
easily constructed where the only substrate-free inter-
mediate is the FMN -form which has high affinityred
for NADq and low or no affinity for ADPR. Should
such an explanation be correct the thermodynamic
consequence follows that the substrate product or
.competitive inhibitor binding per se should strongly
influence the redox properties of flavin. Worth noting
is that the dramatic difference in the redox behaviour
of flavin in Complex I titrated either by artificial
redox dyes or NADqrNADH couple has been docu-
w xmented 59 . It would be of interest to titrate the
enzyme redox components in the presence of ADPR.
Such an experimental approach may be helpful in
studies of possible long distance conformational
changes induced by the substrate binding. It should
be noted that the difference in the precise kinetic
mechanisms as discussed can hardly explain the stim-
ulating effect of ADPR on the reverse electron trans-
 .fer Fig. 6 .
The simplest explanation for unidirectional in-
hibitory effect of ADPR is that at least two nu-
 q .cleotide-binding sites NADH- and NAD -specific
exist in the functionally operative membrane-bound
Complex I, and only NADH-specific site is sensitive
to ADPR. The heterodimeric structure of Complex I
w xwithin the membrane postulated earlier 32 may
serve as a structural basis for such a two-site model.
It is also worth noting that two nucleotide-binding
w xmotifs, one in 51 kDa subunit 39 and another one in
w x39 kDa subunit 41 , were found in the sequence
studies on Complex I. The dramatic difference in the
sensitivity of direct and reverse electron transfer to
rotenone the other highly specific inhibitor of Com-
. w xplex I 60,61 has led us to propose a two-site model
 .for quinone and quinol respectively on the oxygen
side of Complex I. In light of the findings reported
here the similar two binding site arrangement most
likely operates on the substrate side of the enzyme.
The final conclusion on the number and functional
role of the pyridine nucleotide binding sites in Com-
plex I should await further detailed studies of the
effects of ADPR and other catalytically inert nu-
cleotide analogues on all NADqrNADH and
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NADHrNADPH-dependent reactions catalyzed by
the intact and resolved enzyme preparations. These
studies are currently underway in our laboratory.
Taken together with the results presented in this
w xreport the data presently available 58,60,61 suggest
qthat Dm -dependent reverse electron transfer cat-H
alyzed by Complex I is not a simple reversal of
qDm -generating NADH oxidation.H
5. Note added in proof
After the manuscript was accepted two papers
appeared which are relevant to the present studies.
Based on some controversies about the stoichiometry
of the EPR-detectable iron-sulfur clusters in Complex
I, a monomeric structure of the enzyme comprising 2
FMN and 8 different Fe-S clusters has been proposed
S.P.J. Albracht, A.M.P. de Jong, Biochim. Biophys.
 . .Acta 1318 1997 92–106 . Studies on NADH- and
NADPH-induced lipid peroxidation in submito-
chondrial particles and the effect of rhein on those
reactions have led to the conclusion that Complex I
may distinguish between electron input from NADH
and NADPH by differences in the substrate binding
 . site s M.A. Glinn, C.P. Lee, L. Ernster, Biochim.
 . .Biophys. Acta 1318 1997 246–254 .
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